Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(16):1194-1195; doi:10.1093/jnci/93.16.1194
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Dunn, F. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunn, F. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 16, 1194-1195, August 15, 2001
© 2001 Oxford University Press

NEWS

Clinical Trials Provision Makes Way Into Patients’ Bill of Rights

F. B. Dunn

For nearly a decade, cancer advocates have been pushing for mandated insurance coverage of the so-called routine costs of care for patients enrolled in trials. Denying usual care to patients because they chose to aid research was not only blatantly unfair, they argued, but inhumane too.

Their calls largely languished until 1999, when a chance meeting between then Arizona Congressman Matt Salmon and noted oncologist Sydney Salmon, M.D., at 30,000 feet prompted a flurry of Congressional activity that culminated in this summer’s Senate passage of a Patients’ Bill of Rights that includes the trials provision.

The cancer community paints the provision . . . [Full Text of this Article]

A Tale of Two Salmons


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?